Observation on the Effect of Auricular Acupoint Pressing on Insomnia and Adverse Events in MHD
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
1 other identifier
interventional
120
1 country
1
Brief Summary
Maintenance hemodialysis (MHD) is one of the most important treatments for patients with end-stage renal failure. Studies have found that insomnia is widespread in MHD patients, affecting their quality of life. Auricular acupoint pressing is an effective traditional Chinese medicine treatment for insomnia. This study compared the effects of auricular acupoint pressing and oral estazolam on insomnia in patients with MHD, and evaluated the possibility of auricular acupoint pressing to reduce the incidence of adverse events by improving insomnia in patients with MHD, and to explore the insomnia of MHD patients treated with TCM characteristics. The role and efficacy provide a basis for the treatment of sleep disorders by Chinese medicine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Mar 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedFirst Submitted
Initial submission to the registry
June 23, 2019
CompletedFirst Posted
Study publicly available on registry
June 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2021
CompletedDecember 16, 2020
December 1, 2020
1.3 years
June 23, 2019
December 12, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Pittsburgh sleep quality index(PSQI)score
June 1, 2019 to June 1, 2021
Mortality rate
June 1, 2019 to June 1, 2021
Secondary Outcomes (3)
Incidence of cardiovascular events
June 1, 2019 to June 1, 2021
Cerebrovascular accident rate
June 1, 2019 to June 1, 2021
Gastrointestinal bleeding rate
June 1, 2019 to June 1, 2021
Other Outcomes (1)
Hypersensitive C-reactive protein concentration
June 1, 2019 to June 1, 2021
Study Arms (4)
Control group
NO INTERVENTIONAuricular acupoint pressing group
EXPERIMENTALOral estazolam group
ACTIVE COMPARATORCombined treatment group
ACTIVE COMPARATORInterventions
Use a hard and smooth pill to adhere to the center of the 0.7×0.7cm tape. Hold the puncture clip on the part of the ear which is selected, and give appropriate pressure (揉) to make the patient have heat, hemp, Swelling and painful feeling; patients with sputum press 3-5 times a day, each time 1-2 minutes per hole, and must be pressed once every 15-30 minutes before going to bed every night. Press the point pressure method (press the ear point with a fingertip and press it loosely, each interval is 0.5 seconds. It is better for the patient to feel the swelling and slightly heavy tingling, and the force should not be too heavy. Generally, each time the hole can be pressed 27 times. Each time one side of the ear is selected, the two ear points are used alternately, staying in the summer for 1-3 days, and staying in the winter for 3-7 days.It is not appropriate to have local inflammation of the auricle, frostbite or surface skin ulceration.
The first dose was started from 0.5mg, qn, and taken at 30min-1h before going to bed. If the dose is not effective, gradually increase the amount to 2mg, qn. If the patient has drug-induced liver damage and respiratory depression, it is necessary to stop the drug immediately. Hemorrhoids avoid drinking alcohol during medication.
Eligibility Criteria
You may qualify if:
- Age 18-90 years old,received maintenance hemodialysis treatment for more than 1 year, no history of surgical trauma, infection, trauma in the past 3 months; 2.the current condition is stable, the heart function is grade I, no limb paralysis, speech disadvantages and other sequelae; 3.Informed consent volunteer to participate in this experiment.
You may not qualify if:
- At present, dialysis is inadequate, water and sodium retention is severe;
- combined with severe cardiovascular disease, sequelae of cerebral infarction or history of cerebral hemorrhage, history of COPD, history of myasthenia gravis, history of angle-closure glaucoma, blood system disease, mental system disease or other systemic The disease can not be matched with the experimenter;
- poor compliance or poor medical attitude;
- severe hearing or vision loss, or a very low level of education, can not match the experiment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Guangzho University of Chinese Medicine
Guangzhou, Guangdong, 510405, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 23, 2019
First Posted
June 25, 2019
Study Start
March 1, 2019
Primary Completion
June 1, 2020
Study Completion
January 1, 2021
Last Updated
December 16, 2020
Record last verified: 2020-12